Menopause

Cholesterol around menopause: what to discuss after a higher result

A higher LDL result around menopause deserves a risk review. Understand the next questions about blood pressure, family history and treatment.

A middle-aged woman and a healthcare professional discussing a paper report at a desk.
A lipid result needs your health history. The pictured consultation and report are generated illustrations, not a medical review of this article.

Written and evidence-checked by the VeriNourish Editorial Team against 3 named sources listed below. No licensed clinician reviews this content.

If LDL cholesterol has risen around menopause, ask for a cardiovascular risk review rather than dismissing it as hormonal. The menopause transition is associated with changes in LDL and other risk factors, but your treatment decision depends on more than the timing of your last period (American Heart Association).

Cover illustration: A lipid result needs your health history. The pictured consultation and report are generated illustrations, not a medical review of this article.

Take the whole result to the appointment

Keep the report with its units and any earlier results. Ask what changed: LDL, non-HDL cholesterol, triglycerides or more than one measurement. A trend is useful context, but a single result does not show why it changed. The clinician can review medicines, illnesses and the rest of your history before deciding whether a repeat is appropriate.

Bring information about blood pressure, smoking, diabetes and relatives who developed cardiovascular disease early. Mention early menopause and pregnancy complications too. The 2026 US dyslipidemia guideline incorporates individualized risk assessment rather than using one cholesterol number as the answer for everyone (AHA/ACC guideline).

What has changed in current guidance?

The 2026 guideline uses PREVENT-ASCVD equations to guide primary-prevention decisions and recommends measuring lipoprotein(a), or Lp(a), at least once in adulthood. It includes selective use of ApoB and coronary artery calcium assessment when these can help clarify risk. That does not mean everyone needs every test. Ask which uncertainty a test would resolve for you (AHA/ACC guideline).

Online calculators based on older thresholds may not reproduce the current clinician's recommendation. The same LDL value can lead to different advice for someone with established cardiovascular disease and someone without it. A result in a laboratory's reference interval also does not by itself define your personal treatment goal.

Diet and medication are not competing explanations

The AHA recommends a heart-healthy eating pattern, regular activity, avoiding tobacco and weight management where appropriate; medication may be needed as well. A discussion about a statin is not a judgment that you failed at eating well (AHA).

Our menopause nutrition guide gives a broader food framework. For cholesterol specifically, agree on changes you can repeat and a date for reviewing the result. If you already take a lipid-lowering medicine, do not stop it to test whether menopause alone explains the number.

Questions about hormone therapy belong in their own benefits-and-risks discussion. Do not treat a higher cholesterol result as a reason to start hormones on your own. Finish the appointment with a clear plan: which risk factors need attention, whether medication or another test is indicated, and when the next lipid measurement will be useful.

Frequently asked questions

Can I dismiss higher LDL as a normal part of menopause?

No. The menopause transition can accompany changes in cholesterol, but the result still belongs in an overall cardiovascular risk assessment.

Will every woman need a statin at menopause?

No. Treatment depends on the lipid results and overall risk, including existing disease and other medical factors. Menopause alone is not an automatic prescription.

References

  1. Menopause Transition and Cardiovascular Disease Risk: Top Things to Know · American Heart Association, 2020
  2. 2026 Guideline on the Management of Dyslipidemia · American Heart Association and American College of Cardiology, 2026
  3. Prevention and Treatment of High Cholesterol · American Heart Association